We are live on ! Find out more
EAM

EdenTree Asset Management Portfolio holdings

AUM $328M
1-Year Est. Return 20.4%
This Fund
S&P 500
This Quarter Est. Return
-5.24%
1 Year Est. Return
+20.4%
3 Year Est. Return
+50.17%
5 Year Est. Return
10 Year Est. Return
AUM
$332M
AUM Growth
+$5.28M
Cap. Flow
+$30.5M
Cap. Flow %
9.19%
Top 10 Hldgs %
46.66%
Holding
67
New
4
Increased
12
Reduced
16
Closed
2

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$6.76M
2
MRK icon
Merck
MRK
+$4.73M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.38M
4
AVNT icon
Avient
AVNT
+$2.97M
5
ADI icon
Analog Devices
ADI
+$1.73M

Sector Composition

Rank Sector Weight
1 Industrials 24.45%
2 Technology 23.07%
3 Healthcare 22.08%
4 Communication Services 12.04%
5 Financials 12.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
51
Procter & Gamble
PG
$336B
$1.25M 0.38%
8,656
LSCC icon
52
Lattice Semiconductor
LSCC
$18.5B
$1.19M 0.36%
12,800
-1,355
-10% -$121K
ADSK icon
53
Autodesk
ADSK
$53.1B
$1.13M 0.34%
4,703
IEX icon
54
IDEX
IEX
$17.6B
$1.12M 0.34%
5,900
NVDA icon
55
NVIDIA
NVDA
$5.45T
$1.05M 0.32%
6,050
+1,100
+22% +$202K
RRX icon
56
Regal Rexnord
RRX
$11.7B
$1.01M 0.3%
5,386
-2,564
-32% -$477K
SW
57
Smurfit Westrock
SW
$25.8B
$996K 0.3%
25,000
AOS icon
58
A.O. Smith
AOS
$8.45B
$930K 0.28%
14,100
RYN icon
59
Rayonier
RYN
$6.49B
$902K 0.27%
43,732
NXPI icon
60
NXP Semiconductors
NXPI
$59.2B
$886K 0.27%
4,500
PNR icon
61
Pentair
PNR
$10.6B
$863K 0.26%
9,908
-5,549
-36% -$544K
ABBV icon
62
AbbVie
ABBV
$441B
$609K 0.18%
2,800
AUTL
63
Autolus Therapeutics
AUTL
$572M
$414K 0.12%
300,000
LRCX icon
64
Lam Research
LRCX
$416B
$406K 0.12%
+1,900
New +$425K
NOW icon
65
ServiceNow
NOW
$128B
$392K 0.12%
3,750
PAYX icon
66
Paychex
PAYX
$43.4B
-4,000
Closed -$449K
MICC
67
The Magnum Ice Cream Company N.V.
MICC
$12B
-2,300
Closed -$36.6K

Similar funds

EdenTree Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, EdenTree Asset Management held 67 positions worth $332M, up 1.6% from $326M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

EdenTree Asset Management deployed $30.5M of net new capital in Q1 2026, opening 4 new positions and adding to 12 existing holdings. Its largest new stake was AstraZeneca: 117,184 shares worth $22.7M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 23% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Salesforce, an estimated $6.76M trimmed.

  • EdenTree Asset Management's largest Q1 2026 buy was AstraZeneca: 117,184 shares worth $22.7M.
  • EdenTree Asset Management added most to Boston Scientific in Q1 2026, an estimated $7.61M increase.
  • EdenTree Asset Management's biggest Q1 2026 reduction was Salesforce, cutting an estimated $6.76M.
  • EdenTree Asset Management fully exited Paychex in Q1 2026, selling an estimated $449K.
  • EdenTree Asset Management's ten largest holdings make up 47% of its $332M portfolio in Q1 2026.
  • EdenTree Asset Management opened 4 new positions and closed 2 in Q1 2026.
  • EdenTree Asset Management's portfolio value rose 1.6% quarter-over-quarter to $332M.

Based on EdenTree Asset Management's 13F filing for Q1 2026, filed 14 May 2026.